Hemostasis | Sex | Age | pTNM stage | Blood | Operation time/ | Recurrent nerve |
---|---|---|---|---|---|---|
methods | (M/F) | (y/o) | loss (ml) | thoracotomy time (min) | palsy (y/n) | |
Group E | M | 75 | pT1bN0M0 I | 1249 | 703/286 | y (bilateral) |
M | 67 | pT3N1M0 III | 1343 | 500/186 | n | |
M | 64 | pT3N0M0 II | 669 | 503/198 | y | |
M | 57 | pT1bN0M0 III | 389 | 518/212 | y (bilateral) | |
M | 49 | pT4N0M1 IVb | 200 | 379/153 | n | |
M | 51 | pT3N1M0 III | 100 | 395/210 | n | |
M | 60 | pT1bN1M0 II | 500 | 476/160 | y | |
M | 61 | pT3N2M0 III | 600 | 502/235 | y | |
F | 57 | pT3N0M0 II | 208 | 640/160 | n | |
Average ± S.D. | 60.1 ± 8.0 | 584.2 ± 446.4 | 512.9 ± 103.6/200.0 ± 42.5 | Complication rate; 55.6%* | ||
Group N | M | 63 | pT2N1M0 II | 795 | 594/220 | n |
M | 61 | pT2N0M0 II | 3000 | 660/240 | y | |
M | 67 | pT3N0M1 IVb | 555 | 429/190 | n | |
M | 66 | pT1aN0M0 0 | 500 | 499/170 | n | |
M | 68 | pT3N1M0 III | 691 | 590/235 | n | |
M | 66 | pT2N2M0 III | 2140 | 513/199 | n | |
M | 64 | pT3N0M0 II | 250 | 545/264 | n | |
M | 70 | pT1aN0M0 0 | 765 | 558/281 | n | |
M | 76 | pT2N0M0 II | 2992 | 472/239 | n | |
M | 63 | pT1bN0M0 I | 788 | 623/353 | n | |
M | 72 | pT3N1M0 III | 278 | 466/202 | n | |
M | 74 | pT1bN0M0 I | 300 | 561/324 | n | |
F | 74 | pT2N0M0 II | 675 | 355/236 | n | |
M | 56 | pT3N2M0 III | 100 | 435/195 | n | |
M | 74 | pT1aN0M0 0 | 319 | 541/284 | n | |
M | 63 | pT1bN0M0 I | 400 | 508/272 | n | |
M | 69 | pT3N1M0 III | 757 | 621/273 | n | |
M | 75 | pT1bN0M0 I | 341 | 708/374 | n | |
M | 63 | pT1bN0M0 I | 203 | 618/351 | n | |
Average ± S.D | 67.6 ± 5.6 | 834.2 ± 877.9 | 541.9 ± 88.0/258.0 ± 59.3 | Complication rate; 5.3% |